IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
Mayo Clinicmonoclonal_antibodyPhase 2Dormant
BBB
76/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 65/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Recurrent Adult Diffuse Small Cleaved Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine Case Comprehensive Cancer Center | Phase 2 | BBB |
ETOPOSIDE Fred Hutchinson Cancer Center | Phase 3 | BBB |
Cyclophosphamide Case Comprehensive Cancer Center | Phase 3 | BBB |
CYCLOSPORIN A National Cancer Institute (NCI) | Phase 2 | BB |
Cediranib National Cancer Institute (NCI) | Phase 2 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →